SCHEMBL29201238

SCHEMBL29201238

Nc1ncnc2c1c(I)nn2Br

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DYRK1A Q13627 4/20 0.50
DYRK3 O43781 3/20 0.50
RPS6KB1 P23443 3/20 0.50
CSNK1A1 P48729 3/20 0.50
CSNK1D P48730 3/20 0.50
CLK2 P49760 3/20 0.50
IRAK1 P51617 3/20 0.50
SLK Q9H2G2 3/20 0.50
CLK4 Q9HAZ1 3/20 0.50
SRC P12931 3/20 0.50
CDK1 P06493 2/20 0.50
ROS1 P08922 2/20 0.50
CDK2 P24941 2/20 0.50
CDK5 Q00535 2/20 0.50
NTRK3 Q16288 2/20 0.50
JAK2 O60674 2/20 0.50
PRKD3 O94806 2/20 0.50
MAP4K4 O95819 2/20 0.50
PRKACA P17612 2/20 0.50
MARK3 P27448 2/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22430336 0.79 ADK (0.51) DYRK1ADYRK3RPS6KB1CSNK1A1CSNK1D
SCHEMBL22748995 0.79 DYRK3 (0.51) DYRK1ADYRK3RPS6KB1CSNK1A1CSNK1D
SCHEMBL13218401 0.78 SRC (0.50) DYRK1ADYRK3RPS6KB1CSNK1A1CSNK1D
SCHEMBL130592 0.78 SRC (0.50) DYRK1ADYRK3RPS6KB1CSNK1A1CSNK1D
SCHEMBL15471369 0.74 SRC (0.58) RPS6KB1CSNK1A1CSNK1DCLK2SLK
SCHEMBL868744 0.74 PIK3CD (0.51) DYRK1ADYRK3RPS6KB1CSNK1A1CSNK1D
SCHEMBL868687 0.74 ABL1 (0.58) SRCKDRRETEGFRPIK3CG
SCHEMBL21950482 0.74 MAPK1 (0.60) DYRK1ADYRK3RPS6KB1CSNK1A1CSNK1D
SCHEMBL4828016 0.73 SRC (0.46) DYRK1ADYRK3RPS6KB1CSNK1A1CSNK1D
SCHEMBL24096480 0.73 JAK2 (0.86) DYRK1ADYRK3RPS6KB1CSNK1A1CSNK1D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113968842-B Ibutinib intermediate compound 鲁南制药集团股份有限公司 2024-05-03 CN disclosed
CN-113968842-A Ibrutinib intermediate compound 鲁南制药集团股份有限公司 2022-01-25 CN disclosed